Trading analysis backed by real performance data

Abbott Laboratories beat Q1 revenue estimates but cut full-year EPS guidance following its acquisition of Exact Sciences. The stock faced immediate selling pressure as investors weighed growth prospects against near-term margin dilution.

Allbirds (BIRD) has been downgraded to Sell as analysts question management's ability to execute a pivot into AI cloud infrastructure and enterprise sales.

Canada's expansion of assisted suicide programs is drawing scrutiny from analysts who view the policy as a symptom of a strained, government-controlled healthcare system struggling with fiscal sustainability.

JPMorgan's Marko Kolanovic warns that the 10% S&P 500 rally is driven by systematic CTA buying rather than fundamental geopolitical or macro factors.

IonQ shares spiked on a new DARPA contract, fueling a volatile rally in the 2x leveraged IONX ETF. Traders must account for daily rebalancing decay before chasing the momentum.

Bitcoin dominance is masking a lack of breadth in the crypto market, signaling a defensive late-cycle reset rather than a sustained bull run.

CFTC Chair Rostin Behnam is moving forward with an aggressive rulemaking agenda despite criticism from Democratic lawmakers over the lack of bipartisan consensus.

Minnesota prosecutors have charged an ICE agent with assault and issued an arrest warrant following the deaths of Renee Good and Alex Pretti in Minneapolis.

The SEC CLARITY Act roundtable began today in Washington as the Senate Banking Committee prepares for a late-April markup of the major crypto regulatory bill.

Walmart is investing $9 billion to renovate 650 stores across 47 states, aiming to bolster its physical retail footprint and improve operational efficiency amid shifting consumer demand.